Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Targeted Lapatinib Anti-Her2/ErbB2 Therapy Resistance in Breast Cancer: Opportunities to Overcome a Difficult Problem

2020English

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer With HER2-Overexpression: A Network Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Targeted Therapy in Gastric Cancer

European Surgery - Acta Chirurgica Austriaca
Surgery
2016English

HER2-Orientated Therapy in Early and Metastatic Breast Cancer

Breast Care
SurgeryOncology
2016English

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Cancer Research
Cancer ResearchOncology
2008English

CXCR4-targeted Therapy in Breast Cancer

The Lancet Oncology
Oncology
2018English

Targeted Therapeutic Options and Future Perspectives for HER2-positive Breast Cancer

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy